DECEMBER 2023 NEWSLETTER
The newsletter of the Feinberg School of Medicine Research Office
 |
Evolving Telehealth Research and its Place in Healthcare Delivery |
|
Since the COVID-19 pandemic thrust many providers into telehealth appointments, scientists have been asking questions about the benefits and concerns of telehealth. While telehealth was in use and gathering interest prior to the pandemic, the need for it accelerated during a time when people were encouraged to stay home. Learn more about the NIH-funded research that is studying telehealth for individuals with chronic conditions. |
 |
Feinberg Investigators Recognized on 2023 ‘Highly-Cited’ List |
|
Twelve Feinberg faculty members were named to the 2023 “Highly Cited Researchers” list, published by Clarivate Analytics. The annual list identifies investigators who have demonstrated significant influence in their field through the publication of highly-cited publications during the last decade. |
Faculty ProfileUtilizing Machine Learning to Improve Clinical Care and Scientific ResearchLee Cooper, PhD, is associate professor of Pathology and director of the Division of Computational Pathology. His research is dedicated to improving the accuracy, “explainability” and efficiency of machine learning solutions to problems like diagnosis, prognostication and treatment response prediction. |
|
Staff ProfileSupporting and Mentoring Research AdministrationMelanie Mkrdichian is the associate director of research administration in the Basic Science Administration at Feinberg. In her current role as associate director of research administration within the Basic Science Administration she leads a team of 18 research administrators and is committed to mentorship and training. |
|
Student ProfilePursuing Translational Cancer ResearchJamie Nelly Guillen Magaña is a fourth-year PhD student in the Driskill Graduate Program. She is working in the laboratory of Leonidas Platanias, MD, PhD, to understand how modulation of the gene SLFN12 could serve as a therapeutic approach for acute myeloid leukemia. |
|
Campus Events |
||||||||
|
Research in the NewsHow to Protect Your Lungs and Breathe Easier, Especially As You Age Can Little Actions Bring Big Joy? Researchers Find ‘Micro-Acts’ Can Boost Well-being Running vs. Walking: Which Is Better for Lasting Health? |
NUCATS CornerInstitute Relaunches Office HoursIf you are new to NUCATS, part of a well-established research team or somewhere in-between, please consider taking advantage of the Institute's monthly office hours. Join NUCATS Institute Senior Navigator Toddie Hays to learn more about the resources and services available to help facilitate and accelerate your clinical and translational research. |
|
Sponsored ResearchTitle: The Young Gut Microbiome: A Fountain of Youth for Brain Injury in the Aged?
|
|
Sponsored ResearchTitle: The Role of Telehealth in Improving Access to and Costs of Unscheduled Care Among Lower-Income Individuals
|
|
Breakthroughs PodcastHow Mitochondria Inform Disease Discoveries with Navdeep Chandel, PhDPioneering research from Navdeep Chandel, PhD, over the last 20 years has proven mitochondria are major players in lung disease, cancer, brain disease and immune-related diseases. In this episode he discusses how his team’s recent findings could advance the design and implementation of new therapies. |
|
New FacultyJustin Ryder, PhD, joined Feinberg in April as associate professor of Surgery and Pediatrics in the Division of Pediatric Surgery. He is also vice chair of research for the Department of Surgery at Lurie Children’s Hospital. His research interests are focused on understanding the biology underlying treatment response for pediatric obesity. The goal of his NIH-funded research is to expedite the translation of treatment from adults to children for the disease of obesity and improve short-term and long-term outcomes for youth with obesity. His work spans the continuum of treatment with studies focused on lifestyle modification, medication and surgery. |
|
Galter LibraryConducting Systematic and Scoping ReviewsSystematic reviews and scoping reviews offer comprehensive insights into existing literature or evidence on a specific topic. At the heart of these reviews lies a structured search process. Get insight from a Galter librarian on how to conduct these reviews and join upcoming classes. |
|
High Impact ResearchAzcorra M, Gaertner Z, Davidson C, He Q, Kim H, Nagappan S, Hayes CK, Ramakrishnan C, Fenno L, Kim YS, Deisseroth K, Longnecker R, Awatramani R, Dombeck DA. Unique functional responses differentially map onto genetic subtypes of dopamine neurons. Nature Neuroscience. 2023;26(10):1762-1774. Blinder VS, Deal AM, Ginos B, Jansen J, Dueck AC, Mazza GL, Henson S, Carr P, Rogak LJ, Weiss A, Rapperport A, Jonsson M, Spears PA, Cella D, Gany F, Schrag D, Basch E. Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39). Journal of Clinical Oncology. 2023;41(29):4652. Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, Belani HK, Anderson BJ, Huling JD, Tignanelli CJ, Thompson JL, Pullen M, Wirtz EL, Siegel LK, Proper JL, Odde DJ, Klatt NR, Sherwood NE, Lindberg SM, Karger AB, Beckman KB, Erickson SM, Fenno SL, Hartman KM, Rose MR, Mehta T, Patel B, Griffiths G, Bhat NS, Murray TA, Boulware DR. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infectious Diseases. 2023;23(10):1119-1129. Cao Y, Liu H, Lu SS, Jones KA, Govind AP, Jeyifous O, Simmons CQ, Tabatabaei N, Green WN, Holder JL, Jr., Tahmasebi S, George AL, Jr., Dickinson BC. RNA-based translation activators for targeted gene upregulation. Nature Communications. 2023;14(1):6827. |
Featured CoreTransgenic and Targeted Mutagenesis LaboratoryThe Transgenic and Targeted Mutagenesis Laboratory (TTML) is a shared resource designed to produce genetically engineered mice for our investigators. Key services:
|
NIH NewsNew NIH Director: Monica Bertagnolli, MD Monica M. Bertagnolli, MD, started November 9 as the 17th director of the National Institutes of Health, the nation’s biomedical research agency and largest public funder of biomedical research in the world. She is the first surgeon and second woman to hold the position. Nominated by President Biden, Bertagnolli was confirmed on a bipartisan basis by the U.S. Senate on November 7. Growing up in rural Wyoming, Bertagnolli experienced and saw firsthand the challenges faced by rural communities to access medical care and participate in medical research. Due to that lived experience, equity is a core value that drives all her efforts, which includes ensuring NIH research is equitable and accessible to all people from all walks of life regardless of income or zip code. Prior to serving as NIH director, Bertagnolli was a cancer surgeon for over 45 years. She was elected to the National Academy of Medicine in 2021. You Are Invited to Participate in a Pilot of Data Management and Sharing Plan Templates The Federal Demonstration Partnership (FDP) is an association of federal agencies, research policy organizations and academic research institutions with the mission of streamlining the administration of federally-sponsored research and create resources that are available to the research enterprise. NIH has worked closely with them to implement their Data Management and Sharing (DMS) Policy that went into effect in January 2023. They are seeking feedback on two different templates that will assist in the DMS Plan. These templates are available on the FDP website to try. They encourage researchers to use the alpha and bravo template versions when preparing DMS plans, and submit the FDP survey with feedback on their experience. |
Funding OpportunitiesAlzheimer’s Drug-Development Program (U01 Clinical Trial Optional)
Mood and Psychosis Symptoms During the Menopause Transition (R01 Clinical Trial Optional)
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
More Resources |
Thank You For ReadingWe welcome your feedback. Please share it with us via email. |
|
|
